Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Farmaceutica RemediaLTS:0M8I 58 Days Payable is 163.78 as of Mar. 2026, which is 5% above its 10-year median of 156.24. GuruFocus rates LTS:0M8I with a GF Score™ of 58/100 and a GF Value™ of lei0.23. The stock has 8 warning signs investors should review. Among 115 Medical Distribution companies, Farmaceutica Remedia ranks better than 86.09% on this metric.
The historical rank and industry rank for Farmaceutica Remedia's Days Payable or its related term are showing as below:
LTS:0M8I'
s Days Payable Range Over the Past 10 Years
Min: 139.32 Med: 156.24 Max: 204.2
Current: 148.23
During the past 13 years, Farmaceutica Remedia's highest Days Payable was 204.20. The lowest was 139.32. And the median was 156.24.
LTS:0M8I's Days Payable is ranked better than 86.09% of 115
companies
in the Medical Distribution industry
Industry Median: 79.11
vs LTS:0M8I: 148.23
Farmaceutica Remedia's Days Payable
increased
from Mar. 2025 (152.94) to Mar. 2026 (163.78).
It may suggest that Farmaceutica Remediadelayed paying its suppliers.
Farmaceutica Remedia Days Payable Related Terms
Farmaceutica Remedia Days Payable Historical Data
* Premium members only.
The historical data trend for Farmaceutica Remedia's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0M8I vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, Farmaceutica Remedia's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farmaceutica Remedia Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Days Payable distribution charts can be found below:
* The bar in red indicates where Farmaceutica Remedia's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Farmaceutica Remedia's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farmaceutica Remedia (LTS:0M8I) has a Days Payable of 163.78 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Farmaceutica Remedia and its competitors. This is near median its historical median of 156.24. Over the past decade, Farmaceutica Remedia's Days Payable has ranged from 139.32 to 204.20. According to the industry distribution chart, Farmaceutica Remedia ranks #16 out of 115 companies in the Medical Distribution industry, placing it in the top 13.9%.
Is Farmaceutica Remedia's Days Payable too high?
Farmaceutica Remedia's current Days Payable of 163.78 is near median its 10-year median of 156.24. Over the past 10 years, this metric has ranged from a low of 139.32 to a high of 204.20. The Medical Distribution industry median Days Payable is 79.11. Farmaceutica Remedia's value of 163.78 is 107% above this industry median. Based on the distribution chart, Farmaceutica Remedia ranks #16 out of 115 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Farmaceutica Remedia has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Farmaceutica Remedia's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Farmaceutica Remedia ranks #16 out of 115 companies for Days Payable. This places Farmaceutica Remedia in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 79.11. Farmaceutica Remedia's value of 163.78 is 107% above this benchmark. Historically, Farmaceutica Remedia's own Days Payable has ranged from 139.32 to 204.20 over the past decade. While the company's 10-year median is 156.24 vs. the industry median of 79.11, Farmaceutica Remedia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Farmaceutica Remedia's current Days Payable of 163.78 is 107% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Farmaceutica Remedia and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farmaceutica Remedia's current Days Payable is 163.78, which is near median its own 10-year median of 156.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmaceutica Remedia stock overvalued right now?
Farmaceutica Remedia (LTS:0M8I) has a current Days Payable of 163.78. The stock's GF Value™ is lei0.23, compared to a current price of lei0.25 — trading 8.7% above its estimated fair value. The current Days Payable is 163.78, which is near median its 10-year median of 156.24 and 107% above the Medical Distribution industry median of 79.11. Farmaceutica Remedia's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Farmaceutica Remedia (LTS:0M8I), the current Days Payable is 163.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Farmaceutica Remedia (LTS:0M8I) Overvalued in 2026?
Based on GuruFocus' analysis, Farmaceutica Remedia stock appears to be overvalued.
The current stock price of lei0.25 is trading 8.7% above its estimated GF Value™ of lei0.23.
Key valuation signals for LTS:0M8I:
Days Payable: 163.78 (near median its 10-year median of 156.24)
GF Value™: lei0.23 vs. price of lei0.25 (8.7% above fair value)
Industry Position: 107% above the Medical Distribution median (#16 of 115)
No single metric tells the full story. See the LTS:0M8I stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.
58GF Score
Get the complete analysis for LTS:0M8I
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0M8I has been successfully added to your 
